Cargando…

Serum Human Epididymis Protein 4 as a Prognostic Marker in Cervical Cancer

OBJECTIVES: The objective is to evaluate the prognostic value of serum human epididymis protein 4 (HE4) as a tumor marker in patients with cervical cancer. METHODS: Sixty-seven patients with cervical cancer treated at Seoul National University Bundang Hospital from September 2014 to May 2018 were re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hwang, Woo Yeon, Suh, Dong Hoon, Kim, Kidong, Kim, Yong Beom, No, Jae Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9072869/ https://www.ncbi.nlm.nih.gov/pubmed/35506739 http://dx.doi.org/10.1177/10732748221097778

Ejemplares similares

The upper limit of optimal tumor size in patients with FIGO 2018 stage IB2 cervical cancer undergoing radical hysterectomy
por: Hwang, Woo Yeon, et al.
Publicado: (2020)

Aspiration biopsy versus dilatation and curettage for endometrial hyperplasia prior to hysterectomy
por: Hwang, Woo Yeon, et al.
Publicado: (2021)

Clinical features that affect the number of pelvic lymph nodes harvested in patients with cervical cancer stage IB1 to IIA2
por: Choi, Yae Ji, et al.
Publicado: (2021)

Difluoromethylornithine Induces Apoptosis through Regulation of AP-1 Signaling via JNK Phosphorylation in Epithelial Ovarian Cancer
por: Hwang, Woo Yeon, et al.
Publicado: (2021)

Efficacy and safety of skin-adhesive low-level light therapy for overactive bladder: a Phase III study
por: Hwang, Woo Yeon, et al.
Publicado: (2022)

Risk Factor and Treatment of Vaginal Intraepithelial Neoplasia After Hysterectomy for Cervical Intraepithelial Neoplasia
por: Kim, Ju-Hyun, et al.
Publicado: (2022)

Clinicopathologic and protein markers distinguishing the “polymerase epsilon exonuclease” from the “copy number low” subtype of endometrial cancer
por: Kim, Kidong, et al.
Publicado: (2022)

Matched-Case Comparisons in a Single Institution to Determine Critical Points for Inexperienced Surgeons’ Successful Performances of Laparoscopic Radical Hysterectomy versus Abdominal Radical Hysterectomy in Stage IA2-IIA Cervical Cancer
por: Suh, Dong Hoon, et al.
Publicado: (2015)

Stereotactic ablative body radiotherapy boost for cervical cancer when brachytherapy boost is not feasible
por: Lee, Tae Hoon, et al.
Publicado: (2021)

Post-debulking circulating tumor cell as a poor prognostic marker in advanced stage ovarian cancer: A prospective observational study
por: Kim, Miseon, et al.
Publicado: (2019)

The association between diarrhea and serum cytokines in patients with gynecologic cancer treated with surgery and pelvic chemoradiotherapy
por: Eom, Keun-Yong, et al.
Publicado: (2021)

Efficacy of methotrexate therapy in patients with tubal pregnancy and a serum human chorionic gonadotropin level above 10,000 IU/L
por: Kim, Kidong, et al.
Publicado: (2014)

Malacoplakia of the Epididymis
por: Kang, Yu Jin, et al.
Publicado: (2013)

Maximum daily dose of G-CSF is critical for preventing recurrence of febrile neutropenia in patients with gynecologic cancer: A case–control study
por: Kim, Nam Kyeong, et al.
Publicado: (2022)

Feasibility of extended cycles of neoadjuvant chemotherapy in patients with advanced ovarian cancer in terms of prognosis and surgical outcomes
por: Kim, Nam Kyeong, et al.
Publicado: (2023)

A simplified two-marker immunohistochemistry strategy for Lynch syndrome screening in endometrial cancer patients
por: Aiob, Ala, et al.
Publicado: (2023)

Prognostic Value of Log Odds of Positive Lymph Nodes after Radical Surgery Followed by Adjuvant Treatment in High-Risk Cervical Cancer
por: Kwon, Jeanny, et al.
Publicado: (2016)

Systemic Inflammatory Response Markers and CA-125 Levels in Ovarian Clear Cell Carcinoma: A Two Center Cohort Study
por: Kim, Hee Seung, et al.
Publicado: (2016)

Use of a ring retractor to facilitate specimen removal in laparoscopic surgery
por: Hong, Deok Ho, et al.
Publicado: (2020)

Long-term survival after intraperitoneal chemotherapy with paclitaxel-cisplatin for recurrent primary peritoneal cancer resistant to multiple lines of intravenous chemotherapy
por: Hue, Hyejeong, et al.
Publicado: (2019)

HOXB9 Overexpression Confers Chemoresistance to Ovarian Cancer Cells by Inducing ERCC-1, MRP-2, and XIAP
por: Suh, Dong Hoon, et al.
Publicado: (2023)

Synaptonemal Complex Protein 3 Is a Prognostic Marker in Cervical Cancer
por: Cho, Hanbyoul, et al.
Publicado: (2014)

Role of limonin in anticancer effects of Evodia rutaecarpa on ovarian cancer cells
por: Bae, Jae Ryul, et al.
Publicado: (2020)

Survival impact of extended cycles of second-line chemotherapy in platinum-sensitive relapsed ovarian cancer patients with residual tumor after six cycles
por: Kim, Se Ik, et al.
Publicado: (2020)

Pathologic discrepancies between colposcopy-directed biopsy and loop electrosurgical excision procedure of the uterine cervix in women with cytologic high-grade squamous intraepithelial lesions
por: Kim, Se Ik, et al.
Publicado: (2019)

Clinical Implication of PD-L1 Expression in Patients with Endometrial Cancer
por: Kim, Yeorae, et al.
Publicado: (2023)

Nomogram predicting risk of lymphocele in gynecologic cancer patients undergoing pelvic lymph node dissection
por: Yoo, Baraem, et al.
Publicado: (2017)

Clinical evaluation of a droplet digital PCR assay for detecting POLE mutations and molecular classification of endometrial cancer
por: Kim, Gilhyang, et al.
Publicado: (2021)

Diagnostic value of serum human epididymis protein 4 in esophageal squamous cell carcinoma
por: Liu, Shi-Yuan, et al.
Publicado: (2020)

Primary Malignant B-cell Lymphoma of the Epididymis
por: Suh, Jungyo, et al.
Publicado: (2015)

Machine Learning Models to Predict Survival Outcomes According to the Surgical Approach of Primary Radical Hysterectomy in Patients with Early Cervical Cancer
por: Kim, Se Ik, et al.
Publicado: (2021)

Differential expression and localization of tight junction proteins in the goat epididymis
por: Kim, Sung Woo, et al.
Publicado: (2022)

Mutually exclusive antiproliferative effect of cell line‐specific HOX inhibition in epithelial ovarian cancer cell lines: SKOV‐3 vs RMUG‐S
por: Kim, Miseon, et al.
Publicado: (2020)

Evaluation of Serum Human Epididymis Protein 4 Levels in Women with Polycystic Ovary Syndrome
por: Hancerliogullari, Necati, et al.
Publicado: (2019)

Clinical significance of serum human epididymis protein 4 in liver fibrosis: An experimental study
por: Hou, Yulei, et al.
Publicado: (2020)

Major clinical research advances in gynecologic cancer in 2011
por: Suh, Dong Hoon, et al.
Publicado: (2012)

Determination of reference intervals of serum levels of human epididymis protein 4 (HE4) in Chinese women
por: Tian, Yaping, et al.
Publicado: (2015)

Diagnostic Performance of Serum Human Epididymis Protein 4 (HE4) for Prediction of Malignancy in Ovarian Masses
por: Dewan, Rupali, et al.
Publicado: (2019)

Clinical Usefulness of Human Epididymis Protein 4 in Lung Cancer
por: Choi, Soo In, et al.
Publicado: (2017)

Factors associated with patients’ choice of physician in the Korean population: Database analyses of a tertiary hospital
por: Kim, Kidong, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_msll14hkrtu0kt57d8bn32k1b3